Pennsylvania Attorney General Josh Shapiro issued the following news release:. Attorney General Josh Shapiro today announced criminal charges against 51 people for selling heroin, fentanyl, illegal prescription opioids, cocaine, and other drugs in Allegheny County. Many of the arrests in today's roundup were for people considered mid-level drug dea
The American Herbal Products Association issued the following news release:. In a letter to the editor submitted to JAMA Open Network, American Herbal Products Association President Michael McGuffin stressed that the herbal products industry shares concerns about unapproved drugs masquerading as dietary supplements, as outlined in a recent article,
Oct. 19 Maryland Attorney General Brian Frosh on Friday appealed to the U.S. Supreme Court an earlier decision by a federal court that struck down a Maryland law to curb unreasonable price increases for generic drugs. In response to an industry challenge, the 4th U.S. Circuit Court of Appeals decided in April that the first-of-its-kind legislatio
BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology and immunology, today disclosed additional data from the in-depth analyses of biopsies of the dual combination arm of the Phase 2 a COMBAT/KEYNOTE-202 study, evaluating patients with metastatic pancreatic adenocarcinoma treated with BL-8040 in combination with KEYTRUDA..
Valley Cottage, NY 10/19/2018 A new study by FMI titled' Biopharmaceutical Contract Manufacturing Market: Global Industry Analysis 2012 2016 and Opportunity Assessment 2017 2027', has listed out the key points being considered by Biopharmaceutical contract manufacturing companies to emerge and stay sustainably profitable in the long run
Alzheon is a U.S. clinical-stage biopharmaceutical company developing medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. Alzheon has offered to sell 2.5 million shares of its common stock in the offering, and the underwriters have an option for 30 days to purchase up to 375 thousand additiona
Castle Creek plans to use this additional funding to support the late-stage development of an investigational drug, diacerein ointment. We are focused on developing CCP-020 as an important treatment for EBS and look forward to targeting the new investment from Fidelity and Valor towards the late-stage development of this investigational drug, said.
-Clearside Biomedical, Inc., a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases, today announced the appointment of Thomas Crawford, CSCP, as Vice President, Supply Chain. Crawfords earlier experience includes supply chain, manufacturing and trade relations management
Merck, known as MSD outside the United States and Canada, today announced the first presentation of preliminary data from a Phase 1 clinical trial evaluating MK-1454, an investigational STING agonist, as monotherapy and in combination with KEYTRUDA , Merck s anti-PD-1 therapy, in patients with advanced solid tumors or lymphomas. MK-1454 is one
Harrisburg, NC 10/19/2018 Global Generic Drugs Market Insights, Forecast To 2025; presents an in-depth assessment of the Generic Drugs including new developments, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, player profiles
Oct. 20 There are more people in need of new hearts than there are hearts available that's a big reason companies like Abbott Laboratories and Medtronic sell advanced implantable pumps called left-ventricular assist devices to circulate a person's blood when their heart can't do the job alone. On Friday, Illinois- based Abbott Labs announced th
Janssen Pharmaceutical Companies, a subsidiary of Johnson and Johnson, issued the following news release:. The Janssen Pharmaceutical Companies of Johnson& Johnson announced today new long-term data from the open-label period of the VOYAGE 1 clinical trial demonstrating that stably maintained rates of skin clearance with TREMFYA (R) treatment achie
Maryland Attorney General Brian Frosh appealed Friday to the U.S. Supreme Court an earlier decision by a federal court that struck down a Maryland law to curb unreasonable price increases for generic drugs. In response to an industry challenge, the 4th U.S. Circuit Court of Appeals decided in April that the first-of-its-kind legislation violates th
Shares of Merrimack Pharmaceuticals Inc plunged in Fridays pre-market session after the clinical-stage oncology company announced it terminated a Phase 2 trial for its treatment of non-small cell lung cancer due to its failure to improve patients chances for survival. In the wake of the move, the Cambridge, Massachusetts- based company is starting
Novotech, the largest Asia-Pacific- based CRO, has acquired Australasian specialist CRO Clinical Network Services, as part of a mutual mission to expand services to biopharma for early phase product development and clinical research through to later phase regional and global trials. Early phase CNS clients, wishing to advance into later phase regio
The Medical Arts Health Research Group will carry out a phase 3 study in the research process, which if successful would lead next to Health Canada and U.S. Food and Drug Administration approval, with further followup research efforts carried out for the medication after public certification on a wider basis. As doctors, nurses and caregivers, find
OncoMed Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced interim results from its ongoing Phase 1 b trial investigating navicixizumab, OncoMed s anti-DLL4/VEGF bispecific antibody, in combination with paclitaxel in patients with...
-Paragon Biosciences today announced the completion of a new capital investment of $71.8 million for Castle Creek Pharma, a Paragon portfolio company. Paragon organized the $71.8 million investment in Castle Creek from respected firms, Fidelity Management& Research Company and Valor Equity Partners, for late-stage development of treatments for rare
Valley Cottage, NY 10/19/2018 Active pharmaceutical ingredients are a key component of the pharmaceutical industry in the 21st century. The manufacturing segment is expected to cross a value of more than US$ 9.3 billion by end 2022 making it imperative for companies to be present in this operation segment of the pharmaceutical filtration mark
Chicago, October 21, 2018 0.30 CET- Gilead Sciences, Inc. and Galapagos NV today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents.
Gilead Sciences, Inc. and Galapagos NV today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents. The data, which are being presented as a...
-Principia Biopharma Inc., a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology, today announced that PRN1008, an oral, reversible covalent Brutons Tyrosine Kinase inhibitor, has been granted orphan-drug designation by the U.S. Food
Bill Cassidy, R- Louisiana, issued the following news release:. U.S. Senator Bill Cassidy, M.D., a member of the Senate health committee, recently joined National Academy of Medicine President Victor Dzau for a panel discussion on "Affordable Medicines: Access, Innovation, and the Public Interest." The panel also featured former Lockheed Martin CEO
Charles E. Grassley, R- Iowa, and Elizabeth Warren, R- Massachusetts, issued the following joint statement applauding the Food and Drug Administration on its action to make more affordable hearing aids available over-the-counter:. "We are pleased that the US Food and Drug Administration will prioritize issuing rules for over-the-counter hearing ai
Takeda Pharmaceutical Company Limited announces that it has received unconditional clearance from the Japan Fair Trade Commission for the proposed acquisition of Shire plc announced on May 8, 2018. We are very pleased to have received unconditional clearance from the Japan Fair Trade Commission for our proposed acquisition of Shire, said Chri